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e appreciate the interest of Dr. Damman and colleagues in our
ublication (1). Although we did pre-specify strict criteria to
iagnose periprocedural myocardial infarction (MI) in patients
ith elevated biomarkers (2), we agree that it may be challenging
o discern procedure-related myonecrosis from the natural evolu-
ion of cardiac biomarkers in patients with acute coronary syn-
romes (ACS) who are being revascularized. This directional
elationship was also present, however, in patients with normal
aseline biomarkers, and delay to percutaneous coronary interven-
ion (PCI) 24 h was an independent predictor of death or MI at
0 days and at 1 year, independent of biomarker elevation at
aseline (Table 5 [1]). Moreover, a clear, independent mortality
azard for patients undergoing late (24 h) PCI was present, an
nd point not subject to detection bias.
We adjusted for baseline differences in the groups by analysis
ccording to Thrombolysis In Myocardial Infarction risk score,
nd with multivariable modeling. In both of these analyses, PCI
elay was a strong, independent predictor of mortality, as well
s the combined end point of death and MI. The risks
ttributable to PCI delay were observed both early (30 days) and
ate (1 year) after hospitalization for the index event. Random-
zed trials in smaller PCI populations with ACS are also
onsistent with our findings (3,4).
The primary aim of our investigation was to specifically examine
he impact of timing of revascularization in a large cohort of
atients with ACS. The rate of mortality for patients treated
edically (1.5% at 30 days and 4.3% at 1 year) was comparable to
hat of patients requiring revascularization, and was not affected by
he timing of revascularization (data not shown). This observation
gain supports the benefit of early angiography in ACS to identify
atients most in need of early revascularization. Prior studies have
xamined the outcomes of patients with ACS according to timing
f coronary angiography, with mixed results (5–7), in part because
he benefits of early revascularization were diluted by the lack of
enefit in patients treated medically. We agree that furthernalyses to understand the mechanistic relationship between PCI
elay and subsequent mortality are warranted; our study was not
esigned for this purpose, and thus we avoided speculation.
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